WallStreetZenWallStreetZen

NASDAQ: CURI
Curiositystream Inc Stock Forecast, Predictions & Price Target

Analyst price target for CURI

Based on 1 analyst offering 12 month price targets for Curiositystream Inc.
Min Forecast
$1.25+21.36%
Avg Forecast
$1.25+21.36%
Max Forecast
$1.25+21.36%

Should I buy or sell CURI stock?

Based on 1 analyst offering ratings for Curiositystream Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CURI stock forecasts and price targets.

CURI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-21

1 of 1

Forecast return on equity

Is CURI forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
20.1%

Forecast return on assets

Is CURI forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

CURI revenue forecast

What is CURI's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$61.8M+8.63%
Avg 2 year Forecast
$69.2M+21.64%
Avg 3 year Forecast
$76.8M+35%
CURI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CURI revenue growth forecast

How is CURI forecast to perform vs Broadcasting companies and vs the US market?
Company
10.34%
Industry
3.97%
Market
9.39%
CURI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CURI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CURI vs Broadcasting Stocks

TickerPricePrice TargetUp/downsideConsensus
CURI$1.03$1.25+21.36%Buy
CMLS$2.79$8.00+186.74%Buy
SJ$0.96N/AN/A
MDIA$2.72N/AN/A
BBGI$0.73N/AN/A

Curiositystream Stock Forecast FAQ

Is Curiositystream Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: CURI) stock is to Buy CURI stock.

Out of 1 analyst, 0 (0%) are recommending CURI as a Strong Buy, 1 (100%) are recommending CURI as a Buy, 0 (0%) are recommending CURI as a Hold, 0 (0%) are recommending CURI as a Sell, and 0 (0%) are recommending CURI as a Strong Sell.

If you're new to stock investing, here's how to buy Curiositystream stock.

What is CURI's revenue growth forecast for 2024-2026?

(NASDAQ: CURI) Curiositystream's forecast annual revenue growth rate of 10.34% is forecast to beat the US Broadcasting industry's average forecast revenue growth rate of 3.97%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.39%.

Curiositystream's revenue in 2024 is $56,889,000.On average, 1 Wall Street analysts forecast CURI's revenue for 2024 to be $3,294,328,784, with the lowest CURI revenue forecast at $3,294,328,784, and the highest CURI revenue forecast at $3,294,328,784. On average, 1 Wall Street analysts forecast CURI's revenue for 2025 to be $3,688,795,337, with the lowest CURI revenue forecast at $3,688,795,337, and the highest CURI revenue forecast at $3,688,795,337.

In 2026, CURI is forecast to generate $4,093,923,149 in revenue, with the lowest revenue forecast at $4,093,923,149 and the highest revenue forecast at $4,093,923,149.

What is CURI's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: CURI) forecast ROA is N/A, which is lower than the forecast US Broadcasting industry average of N/A.

What is CURI's Price Target?

According to 1 Wall Street analyst that have issued a 1 year CURI price target, the average CURI price target is $1.25, with the highest CURI stock price forecast at $1.25 and the lowest CURI stock price forecast at $1.25.

The Wall Street analyst predicted that Curiositystream's share price could reach $1.25 by Mar 21, 2025. The average Curiositystream stock price prediction forecasts a potential upside of 21.36% from the current CURI share price of $1.03.

What is CURI's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: CURI) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.